Universitätsklinik für Gynäkologische Endokrinologie und Reproduktionsmedizin, Innsbruck, Austria.
Arch Gynecol Obstet. 2012 Jul;286(1):231-6. doi: 10.1007/s00404-012-2298-2. Epub 2012 Mar 31.
Depressive symptoms often occur among women of reproductive age. In this article we perform an analysis of existing studies to examine a possible correlation between depression and the use of hormone-based contraceptives.
The computerized databases MEDLINE/PubMed were searched for studies examining the relation between depressive disorders and hormonal contraception of the years 1976-2010.
Data on this topic are limited. At least two confounding variables influence the analysis of the available data and make it difficult to draw firm conclusions: the inconsistent use of the term "depression" and the large number of combined contraceptives which vary in their composition. The association between the use of oral contraceptives and depression is not clear. We found that depression is not a common side effect of hormone-based contraceptives.
Individual, patient-based decisions with consideration of the individual history and predispositions are recommended when starting oral contraceptives. If depressive symptoms or mood changes occur, decisions regarding discontinuation or medication change need to be made on an individual basis.
抑郁症状常发生于育龄期女性。本文通过分析现有研究,旨在探讨抑郁与激素避孕之间的可能相关性。
检索了 1976 年至 2010 年 MEDLINE/PubMed 数据库中有关抑郁障碍与激素避孕之间关系的研究。
关于这一主题的数据有限。至少有两个混杂因素影响对现有数据的分析,使其难以得出明确的结论:“抑郁”这一术语使用不一致,以及组成各异的多种复合避孕药。使用口服避孕药与抑郁之间的关联并不明确。我们发现,抑郁不是激素避孕药的常见副作用。
建议在开始使用口服避孕药时,基于个体情况和考虑个体病史和易感性做出个体化决策。如果出现抑郁症状或情绪变化,需要根据个体情况决定是否停药或更换药物。